Cite
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.
MLA
Grebely, Jason, et al. “Elimination of Hepatitis C Virus Infection among PWID: The Beginning of a New Era of Interferon-Free DAA Therapy.” International Journal of Drug Policy, vol. 47, Sept. 2017, pp. 26–33. EBSCOhost, https://doi.org/10.1016/j.drugpo.2017.08.001.
APA
Grebely, J., Bruneau, J., Bruggmann, P., Harris, M., Hickman, M., Rhodes, T., Treloar, C., & International Network on Hepatitis in Substance Users. (2017). Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy. International Journal of Drug Policy, 47, 26–33. https://doi.org/10.1016/j.drugpo.2017.08.001
Chicago
Grebely, Jason, Julie Bruneau, Philip Bruggmann, Magdalena Harris, Matthew Hickman, Tim Rhodes, Carla Treloar, and International Network on Hepatitis in Substance Users. 2017. “Elimination of Hepatitis C Virus Infection among PWID: The Beginning of a New Era of Interferon-Free DAA Therapy.” International Journal of Drug Policy 47 (September): 26–33. doi:10.1016/j.drugpo.2017.08.001.